These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
376 related items for PubMed ID: 30506990
1. Microarray profiling analysis identifies the mechanism of miR-200b-3p/mRNA-CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor-γ signaling pathway. Xu L, Chen W, Ma M, Chen A, Tang C, Zhang C, Cai L. J Cell Biochem; 2019 Apr; 120(4):5193-5206. PubMed ID: 30506990 [Abstract] [Full Text] [Related]
2. MicroRNA-27a-3p suppression of peroxisome proliferator-activated receptor-γ contributes to cognitive impairments resulting from sevoflurane treatment. Lv X, Yan J, Jiang J, Zhou X, Lu Y, Jiang H. J Neurochem; 2017 Nov; 143(3):306-319. PubMed ID: 28881034 [Abstract] [Full Text] [Related]
3. LncRNA TINCR/microRNA-107/CD36 regulates cell proliferation and apoptosis in colorectal cancer via PPAR signaling pathway based on bioinformatics analysis. Zhang X, Yao J, Shi H, Gao B, Zhang L. Biol Chem; 2019 Apr 24; 400(5):663-675. PubMed ID: 30521471 [Abstract] [Full Text] [Related]
4. Long noncoding RNA PVT1 facilitates high glucose-induced cardiomyocyte death through the miR-23a-3p/CASP10 axis. Yu FR, Xia YW, Wang SB, Xiao LH. Cell Biol Int; 2021 Jan 24; 45(1):154-163. PubMed ID: 33049089 [Abstract] [Full Text] [Related]
5. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer. Lv Z, Wei J, You W, Wang R, Shang J, Xiong Y, Yang H, Yang X, Fu Z. J Transl Med; 2017 Dec 19; 15(1):257. PubMed ID: 29258530 [Abstract] [Full Text] [Related]
6. Silencing of peroxisome proliferator-activated receptor-alpha alleviates myocardial injury in diabetic cardiomyopathy by downregulating 3-hydroxy-3-methylglutaryl-coenzyme A synthase 2 expression. Wang L, Bi X, Han J. IUBMB Life; 2020 Sep 19; 72(9):1997-2009. PubMed ID: 32734614 [Abstract] [Full Text] [Related]
7. CircMAP3K5 promotes cardiomyocyte apoptosis in diabetic cardiomyopathy by regulating miR-22-3p/DAPK2 Axis. Shen M, Wu Y, Li L, Zhang L, Liu G, Wang R. J Diabetes; 2024 Jan 19; 16(1):e13471. PubMed ID: 37735821 [Abstract] [Full Text] [Related]
8. Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP. Fang P, Ye Z, Li R, She D, Zong G, Zhang L, Xue Y, Zhang K. Drug Des Devel Ther; 2023 Jan 19; 17():791-806. PubMed ID: 36936522 [Abstract] [Full Text] [Related]
9. LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy. Yang F, Qin Y, Wang Y, Li A, Lv J, Sun X, Che H, Han T, Meng S, Bai Y, Wang L. Cell Physiol Biochem; 2018 Jan 19; 50(4):1230-1244. PubMed ID: 30355944 [Abstract] [Full Text] [Related]
10. Effects of PPARγ agonist pioglitazone on cardiac fibrosis in diabetic mice by regulating PTEN/AKT/FAK pathway. Zhang XD, Sun GX, Guo JJ, Hu CC, Sun RC, Yu HC. Eur Rev Med Pharmacol Sci; 2021 Jan 19; 25(2):812-819. PubMed ID: 33577036 [Abstract] [Full Text] [Related]
11. Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts. Zhu WS, Tang CM, Xiao Z, Zhu JN, Lin QX, Fu YH, Hu ZQ, Zhang Z, Yang M, Zheng XL, Wu SL, Shan ZX. Oncotarget; 2016 Nov 29; 7(48):78331-78342. PubMed ID: 27823969 [Abstract] [Full Text] [Related]
12. MicroRNA-668-3p Protects Against Oxygen-Glucose Deprivation in a Rat H9c2 Cardiomyocyte Model of Ischemia-Reperfusion Injury by Targeting the Stromal Cell-Derived Factor-1 (SDF-1)/CXCR4 Signaling Pathway. Gao Z, Gao Q, Lv X. Med Sci Monit; 2020 Jan 30; 26():e919601. PubMed ID: 31997826 [Abstract] [Full Text] [Related]
13. miR-34a attenuates myocardial fibrosis in diabetic cardiomyopathy mice via targeting Pin-1. Zhang XL, Zhang G, Bai ZH. Cell Biol Int; 2021 Mar 30; 45(3):642-653. PubMed ID: 33289184 [Abstract] [Full Text] [Related]
14. Perillaldehyde improves diabetic cardiomyopathy by upregulating miR-133a-3p to regulate GSK-3β. Yu YN, Ren YY, Shao ZL, Chen BL, Cui BY, Chao CY, Guo LJ, Guo S, Zhang MX, Wang SX, Zhu ML, Yin YL, Li P. Eur J Pharmacol; 2023 Aug 15; 953():175836. PubMed ID: 37329971 [Abstract] [Full Text] [Related]
15. Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy. Xu D, Zhang X, Chen X, Yang S, Chen H. Life Sci; 2020 Sep 01; 256():117980. PubMed ID: 32561396 [Abstract] [Full Text] [Related]
16. Knockdown of miR-372-3p Inhibits the Development of Diabetic Cardiomyopathy by Accelerating Angiogenesis via Activating the PI3K/AKT/mTOR/HIF-1α Signaling Pathway and Suppressing Oxidative Stress. Han Z, Zhao D, Han M, Zhang R, Hao Y. Oxid Med Cell Longev; 2022 Sep 01; 2022():4342755. PubMed ID: 36160704 [Abstract] [Full Text] [Related]
17. Intra-amniotic delivery of tropomodulin 3 rescues cell apoptosis induced by miR-200b-3p upregulation via non-canonical nuclear factor kappa B pathways in ethylene thiourea induced anorectal malformations fetal rat. Liu P, Li Y, Yao Y, Wang W, Jia H, Bai Y, Yuan Z, Yang Z. Ecotoxicol Environ Saf; 2024 Oct 01; 284():116918. PubMed ID: 39191136 [Abstract] [Full Text] [Related]